These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30647178)

  • 1. Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort.
    Guzman J; Henrey A; Loughin T; Berard RA; Shiff NJ; Jurencak R; Huber AM; Oen K; Gerhold K; Feldman BM; Scuccimarri R; Houghton K; Chédeville G; Morishita K; Lang B; Dancey P; Rosenberg AM; Barsalou J; Bruns A; Watanabe Duffy K; Benseler S; Duffy CM; Tucker LB;
    J Rheumatol; 2019 Jun; 46(6):628-635. PubMed ID: 30647178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
    Guzman J; Oen K; Tucker LB; Huber AM; Shiff N; Boire G; Scuccimarri R; Berard R; Tse SM; Morishita K; Stringer E; Johnson N; Levy DM; Duffy KW; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey S; Bruns A; Campillo S; Benseler S; Chédeville G; Schneider R; Yeung R; Duffy CM;
    Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort.
    Guzman J; Henrey A; Loughin T; Berard RA; Shiff NJ; Jurencak R; Benseler SM; Tucker LB;
    J Rheumatol; 2017 Feb; 44(2):230-240. PubMed ID: 27980015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort.
    Henrey A; Rypdal V; Rypdal M; Loughin T; Nordal E; Guzman J;
    Arthritis Res Ther; 2020 Jan; 22(1):10. PubMed ID: 31941530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
    Glerup M; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Toftedal P; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):507-516. PubMed ID: 30762291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
    Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
    Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).
    Davies R; Carrasco R; Foster HE; Baildam EM; Chieng SEA; Davidson JE; Ioannou Y; Wedderburn LR; Thomson W; Hyrich KL
    Semin Arthritis Rheum; 2016 Oct; 46(2):190-195. PubMed ID: 27422803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry.
    Nguyen K; Barsalou J; Basodan D; Batthish M; Benseler SM; Berard RA; Blanchette N; Boire G; Bolaria R; Bruns A; Cabral DA; Cameron B; Campillo S; Cellucci T; Chan M; Chédeville G; Chetaille AL; Chhabra A; Couture J; Dancey P; De Bruycker JJ; Demirkaya E; Dhalla M; Duffy CM; Feldman BM; Feldman DE; Gerschman T; Haddad E; Heale L; Herrington J; Houghton K; Huber AM; Human A; Johnson N; Jurencak R; Lang B; Larché M; Laxer RM; LeBlanc CM; Lee JJY; Levy DM; Lim L; Lim LSH; Luca N; McGrath T; McMillan T; Miettunen PM; Morishita KA; Ng HY; Oen K; Park J; Petty RE; Proulx-Gauthier JP; Ramsey S; Roth J; Rosenberg AM; Rozenblyum E; Rumsey DG; Schmeling H; Schneider R; Scuccimarri R; Shiff NJ; Silverman E; Soon G; Spiegel L; Stringer E; Tam H; Tse SM; Tucker LB; Turvey S; Twilt M; Duffy KW; Yeung RSM; Guzman J
    Rheumatology (Oxford); 2024 Sep; 63(SI2):SI173-SI179. PubMed ID: 37851400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis.
    Sener S; Aliyev E; Batu ED; Balik Z; Bayindir Y; Cam V; Basaran O; Bilginer Y; Ozen S
    Clin Rheumatol; 2024 Jun; 43(6):2021-2026. PubMed ID: 38683443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort Study.
    Arnstad ED; Rypdal V; Peltoniemi S; Herlin T; Berntson L; Fasth A; Nielsen S; Glerup M; Ekelund M; Zak M; Aalto K; Nordal E; Romundstad PR; Rygg M;
    Arthritis Care Res (Hoboken); 2019 Jul; 71(7):961-969. PubMed ID: 30055093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach.
    Castillo-Vilella M; Giménez N; Tandaipan JL; Quintana S; Modesto C
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):130. PubMed ID: 34419078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort.
    Zamora-Legoff JA; Krause ML; Crowson CS; Muskardin TW; Mason T; Matteson EL
    Clin Rheumatol; 2016 Jun; 35(6):1493-9. PubMed ID: 26825065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
    Guzman J; Oen K; Huber AM; Watanabe Duffy K; Boire G; Shiff N; Berard RA; Levy DM; Stringer E; Scuccimarri R; Morishita K; Johnson N; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey SE; Bruns A; Roth J; Campillo S; Benseler S; Chédeville G; Schneider R; Tse SM; Bolaria R; Gross K; Feldman B; Feldman D; Cameron B; Jurencak R; Dorval J; LeBlanc C; St Cyr C; Gibbon M; Yeung RS; Duffy CM; Tucker LB;
    Ann Rheum Dis; 2016 Jun; 75(6):1092-8. PubMed ID: 25985972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience.
    Chhabra A; Robinson C; Houghton K; Cabral DA; Morishita K; Tucker LB; Petty RE; Larché M; Batthish M; Guzman J
    Rheumatology (Oxford); 2020 Dec; 59(12):3727-3730. PubMed ID: 32402087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration.
    Simonini G; Ferrara G; Pontikaki I; Scoccimarro E; Giani T; Taddio A; Meroni PL; Cimaz R
    Arthritis Care Res (Hoboken); 2018 Jul; 70(7):1046-1051. PubMed ID: 28973842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)].
    Bukovac LT; Vidović M; Lamot L; Perica M; Harjacek M;
    Reumatizam; 2013; 60(1):57-66. PubMed ID: 24003687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1-results of the Canadian model in the Nordic cohort.
    Rypdal V; Guzman J; Henrey A; Loughin T; Glerup M; Arnstad ED; Aalto K; Rygg M; Nielsen S; Herlin T; Fasth A; Berntson L; Rypdal M; Nordal E;
    Arthritis Res Ther; 2019 Dec; 21(1):270. PubMed ID: 31806043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature.
    Halyabar O; Mehta J; Ringold S; Rumsey DG; Horton DB
    Paediatr Drugs; 2019 Dec; 21(6):469-492. PubMed ID: 31673960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry.
    Batthish M; Berard R; Cabral D; Bolaria R; Chédeville G; Duffy C; Gerhold K; Gerschman T; Huber A; Proulx-Gauthier JP; Rosenberg A; Rumsey D; Schmeling H; Shiff N; Soon G; Bruns A; Tucker L; Guzman J;
    Rheumatology (Oxford); 2020 Oct; 59(10):2796-2805. PubMed ID: 32044978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register.
    McErlane F; Foster HE; Davies R; Lunt M; Watson KD; Symmons DP; Hyrich KL
    Rheumatology (Oxford); 2013 Oct; 52(10):1905-13. PubMed ID: 23873820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.